Stockholders' Equity (Details) - USD ($)		1 Months Ended			12 Months Ended
	Nov. 06, 2020	Nov. 30, 2021	Aug. 26, 2021	Jun. 30, 2020	Dec. 31, 2021	Dec. 31, 2020
Stockholders' Equity (Details) [Line Items]
Common stock, authorized					1,000,000,000	1,000,000,000
Common stock issued					23,294,024	23,294,024
Common stock outstanding					19,642,401	19,642,401
Preferred stock, authorized					20,000,000
Number of common stock purchased, shares					81,000
Number of common shares issued for convertible notes, amount (in Dollars)					$ 6.2
Number of common shares issued for convertible notes, shares					1,171,000
Number of common shares issued for services, shares					756,000
Number of stock granted						266,667
Restricted common stock shares granted						100,000
Shares of employee compensation						166,667
Issued shares of common stock						3,540
Description of subscription agreements				●In June 2020, the Company entered into Subscription Agreements with two accredited investors (the “June 2020 Accredited Investors”) pursuant to which the June 2020 Accredited Investors agreed to purchase 114,719 shares of common stock for $200,000.
Description of securities purchase						●During 2020, the Company issued approximately 56,000 shares of common stock pursuant to cashless exercises of common stock purchase warrants and options, other than the June 2020 warrant exercises.
Stock option to board of directors					The Company granted each of the four new Directors appointed June 2021 (“June Directors”) stock options to acquire 62,500 shares of common stock or a total of 250,000 that vest one third a year after each Annual Meeting.  Additionally, the Company added another Director in November 2021 and granted stock options to acquire 29,173 shares of common stock that vest one third a year after each Annual Meeting beginning in 2022.  One of the June Directors did not stand for reelection to the Board of Directors in December 2021 and forfeited 41,667 stock options.  In December 2021, the Company granted additional options to acquire 10,238 shares of common stock each to five of the non-employee Directors, by way of annual compensation under the Company’s compensation policy for non-employee directors and which vests monthly over a one-year-period.   ● The Company granted the previously serving Directors stock options to acquire 93,470 common shares that are vested as the services were rendered. The stock options were granted in lieu of other forms of Board of Director Compensation and was used to eliminate previously accrued Board of Director compensation. The Company also granted to each of Mr. Selzer and Mr. Stern 22,388 stock options to acquire common shares for service in 2021 prior to their resignation as Directors. Upon their resignation as directors in June 2021, 6,997 stock options to each of them were vested and the balance was cancelled.    ●Additionally, the Company granted options to acquire common stock to employees. The options for the majority  vest annually over a three-year period, 100,000 vest equally over a four-year period, and the balance of 100,000 vest upon the achievement of certain market capitalization thresholds or performance conditions.
Vesting rights description						the Company granted Mr. Kumnick and Mr. Broenniman granted options to acquire 1,111,111 and 555,555,respectively, shares of common stock upon their employment. The options granted to Mr. Kumnick and Mr. Broenniman vest 20% at date of the grant with the balance vesting upon achieving certain performance thresholds. The performance thresholds have been met. Additionally, the Company granted options to acquire approximately 422,000 shares of common stock to employees and one service provider in connection with service. The options have a term of ten years with vesting ranging from immediate to a three-year period. All options granted approximated fair value.
Stock compensation expense (in Dollars)					$ 5,475,000	$ 823,000
Restricted stock expense (in Dollars)					1,228,000
Employee Stock Option [Member]
Stockholders' Equity (Details) [Line Items]
Unrecognized compensation costs (in Dollars)					$ 15,597,000
Mr.Thimot [Member]
Stockholders' Equity (Details) [Line Items]
Stock options to acquire					1,200,000
Mr.Smith [Member]
Stockholders' Equity (Details) [Line Items]
Stock options to acquire					600,000
Mr.Kumnick [Member]
Stockholders' Equity (Details) [Line Items]
Stock options to acquire					583,333
Stock options to acquire the cancel shares		300,000
Mr.Broenniman [Member]
Stockholders' Equity (Details) [Line Items]
Stock options to acquire					583,333
Stock options to acquire the cancel shares		200,000
Warrant 1 [Member]
Stockholders' Equity (Details) [Line Items]
Description of warrants				Company entered into and consummated a private transaction pursuant to which a portion of the Company’s $3.00 Warrants were exercised for cash at an exercise price of $2.10 per share. In addition, the holders that exercised the $3.00 Warrants received a $0.15 Warrant for every four $3.00 Warrants exercised. As a result, the Company issued 333,611 shares of common stock and 83,403 $4.50 Warrants in consideration of $700,583.
Warrant 2 [Member]
Stockholders' Equity (Details) [Line Items]
Description of warrants				In addition, the holders that exercised the $1.50 Warrants received a $4.50 Warrant for every two $1.50 Warrants exercised. As a result, the Company issued 154,400 shares of common stock and 77,200 $4.50 Warrants, in consideration of $231,600. Separately, certain holders of the $1.50 Warrants to acquire 59,000 shares of common stock exercised on a cashless basis resulting in the issuance of 18,689 shares of common stock.
Warrant 3 [Member]
Stockholders' Equity (Details) [Line Items]
Description of warrants				In addition, the holders that exercised the $1.80 Warrants also received $4.50 Warrant for every two $1.80 Warrants exercised. As a result, the Company issued 176,000 shares of common stock and 88,000 $4.50 Warrants in consideration of $316,800.
Warrant [Member]
Stockholders' Equity (Details) [Line Items]
Description of warrants					under the terms of the Underwriting Agreement in connection with the Offering, the Company issued underwriters warrants (the “Representative’s Warrants”) to purchase an aggregate of 64,286 shares of common stock (4.5% of the total shares issued in the Offering). The Representative’s Warrants are exercisable at a per share price of $8.75 (equal to 125% of the Offering price of the Company’s common stock). The Representative’s Warrants are exercisable for a term of four and one half years beginning on February 23, 2022.   ● During the year ended December 31, 2020, the Company issued approximately 980,000 common stock warrants in connection with its sale of common stock in the 4th quarter of 2020 for a term of five years at an exercise price $4.50 per share. Of the approximate 980,000 shares, approximately 105,000 shares were issued to a broker-dealer in connection with the sale of common stock.   ●During the year ended December 31, 2020, the Company issued approximately 250,000 common stock warrants for a term of five years at an average exercise price of $4.50 cents in connection with cash exercises of previously issued warrants. The Company recorded a charge of approximately $367,000 in connection with an inducement to the warrant holders who exercised their outstanding warrants.
Securities Purchase Agreements [Member]
Stockholders' Equity (Details) [Line Items]
Description of securities purchase	On October 30, 2020 and on November 6, 2020, Ipsidy Inc. entered into Securities Purchase Agreements with several accredited investors (the “October 2020 Accredited Investors”) pursuant to which the October 2020 Accredited Investors agreed to purchase approximately 1,748,000 shares of the Company’s common stock together with Warrants to acquire approximately 874,000 shares of common stock for a term of five years at an exercise price of $4.50 per share for an aggregate purchase price of approximately $5.24 million. In connection with this private offering, the Company paid a registered broker-dealer, a cash fee of approximately $367,000 and issue the broker-dealer a common stock purchase warrant to acquire approximately 105,000 shares of common stock of the Company exercisable for a term of five years at an exercise price of $4.50 per share.
Public Offering [Member]
Stockholders' Equity (Details) [Line Items]
Number of common stock purchased, shares			1,642,856
Share issued, per share (in Dollars per share)			$ 7
Sale of stock			214,285
Gross proceeds (in Dollars)			$ 11,500,000